Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.24.2.u1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Jul. 31, 2024
Jul. 31, 2023
Cash flows from operating activities:        
Net income (loss) $ (39,566) $ (31,999) $ (67,202) $ (76,223)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Amortization of intangible assets     63,371 77,466
Share-based compensation     6,339 14,955
Depreciation     1,404 2,761
Non-cash interest expense     1,080 1,024
Non-cash property, equipment, software and lease impairment charges     2,293 4,808
Provision for credit loss expense (recovery)     56 4
(Gain) loss on sale of business 0 0 0 682
Provision for (benefit from) income taxes – non-cash     (6,271) (6,913)
Fair value adjustment of warrants (0) (793) (0) (3,645)
Fair value adjustment of interest rate swaps 6,506 (6,935) (1,240) (7,205)
Change in assets and liabilities:        
Accounts receivable     75,004 73,172
Prepaid expenses and other current assets, including long-term     (3,016) (520)
Right-of-use assets     1,351 145
Accounts payable     (603) (4,241)
Accrued expenses and other liabilities, including long-term     (9,568) (17,379)
Lease liabilities     (2,539) (1,081)
Deferred revenues     (56,962) (55,825)
Net cash provided by (used in) operating activities     3,497 1,985
Cash flows from investing activities:        
Purchase of property and equipment     (399) (3,406)
Internally developed software - capitalized costs     (8,796) (5,951)
Sale of SumTotal, net of cash transferred     0 (5,137)
Net cash provided by (used in) investing activities     (9,195) (14,494)
Cash flows from financing activities:        
Shares repurchased for tax withholding upon vesting of restricted stock-based awards     (479) (881)
Payments to acquire treasury stock     0 (8,046)
Net cash provided by (used in) financing activities     (8,255) (11,730)
Effect of exchange rate changes on cash and cash equivalents     (2,427) (472)
Net increase (decrease) in cash, cash equivalents and restricted cash     (16,380) (24,711)
Cash, cash equivalents and restricted cash, beginning of period     146,523 177,556
Cash, cash equivalents and restricted cash, end of period 130,143 152,845 130,143 152,845
Supplemental disclosure of cash flow information:        
Cash and cash equivalents 122,652 147,927 122,652 147,927
Restricted cash 7,491 4,918 7,491 4,918
Cash, cash equivalents and restricted cash, end of period $ 130,143 $ 152,845 130,143 152,845
Term Loan Facility [Member]        
Cash flows from financing activities:        
Principal payments on Term loans     (3,202) (3,202)
Accounts Receivable Facility [Member]        
Cash flows from financing activities:        
Proceeds from facility, net of borrowings     $ (4,574) $ 399